Regulon

Regulon: R-2568

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
181.4814210Pr-143Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3998 ENSG00000074695 LMAN1 P49257
9689 ENSG00000082153 BZW1 Q7L1Q6
334 ENSG00000084234 APLP2 Q06481
3655 ENSG00000091409 ITGA6 P23229
5216 ENSG00000108518 PFN1 P07737
3312 ENSG00000109971 HSPA8 A8K7Q2
10114 ENSG00000110422 HIPK3 Q9H422
2030 ENSG00000112759 SLC29A1 Q99808
55825 ENSG00000115425 PECR Q9BY49
6249 ENSG00000130779 CLIP1 A0A024RBR1
6272 ENSG00000134243 SORT1 Q99523
55293 ENSG00000151116 UEVLD Q8IX04
6565 ENSG00000163406 SLC15A2 Q16348
25932 ENSG00000169504 CLIC4 Q9Y696
4973 ENSG00000173391 OLR1 A0A024RAU0
8073 ENSG00000184007 PTP4A2 Q12974
5660 ENSG00000197746 PSAP P07602
4067 ENSG00000254087 LYN P07948

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
DIPYRIDAMOLESLC29A1Small moleculeINHIBITOR3',5'-cyclic phosphodiesterase inhibitor40
FORIGERIMODHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
BOSUTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein42
BAFETINIBLYNSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
JNJ-26483327ERBB2Small moleculeINHIBITORTyrosine-protein kinase FYN inhibitor10
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
FORIGERIMOD ACETATEHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
TOLIMIDONELYNSmall moleculePOSITIVE ALLOSTERIC MODULATORTyrosine-protein kinase Lyn positive allosteric modulator20
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2568

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs